Market by Product, Technique Type, Application, and Country | Forecast 2021-2028
The Asia-Pacific pharmaceutical filtration market is predicted to exhibit growth at 10.02% of CAGR during the estimated years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries assessed in this market include:
• India
• China
• Japan
• Australia
& New Zealand
• South
Korea
• ASEAN
countries
• Rest
of APAC
In
Asia-Pacific, the rise in the pharmaceutical filtration market is mainly owing
to the high population, a surge in disposable income, and an increased
occurrence of chronic diseases, including malaria, polio, and rabies. Moreover,
the high demand for pharmaceutical filtration products is also influencing the
progress of the pharmaceutical filtration market across the region.
Furthermore,
China is anticipated to display a stable growth in the studied market due to
the advancement in the healthcare infrastructure, an increase in the production
of APIs and biologics, and the progressing R&D sector. Additionally, the
presence of a high population base, rise in demand for advanced medical
facilities, and R&D activities in the pharma industry are further expected
to motivate China's pharmaceutical filtration market.
In
Japan, however, the aging population has put significant pressure on government
healthcare expenditure. This has influenced the government to implement
specific cost-effective measures, such as the marketing of generic drugs and
biennial drug pricing revisions. Additionally, the elevated demand for generic
drugs has led the big pharmaceutical companies to form joint ventures to meet
the high demand. Hence, these factors augment the demand for pharmaceutical
filtration products, thereby fueling the Japanese pharmaceutical filtration
market on a growth path.
Asahi Kasei Corporation is involved in different
businesses, including chemicals, fibers, construction materials, and
electronics. Its primary business segments comprise chemicals and fibers, homes
and construction materials, healthcare, and electronics. Through these
segments, the company produces petrochemical products, specialty products, and
pharmaceuticals, among others. It has its operations in numerous countries,
with its headquarter in Tokyo, Japan.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
ASIA-PACIFIC
PHARMACEUTICAL FILTRATION MARKET - SUMMARY
2.
INDUSTRY
OUTLOOK
2.1.
PORTER’S
FIVE FORCES MODEL
2.1.1.
THREAT
OF NEW ENTRANTS
2.1.2.
THREAT
OF SUBSTITUTE PRODUCTS
2.1.3.
BARGAINING
POWER OF BUYERS
2.1.4.
BARGAINING
POWER OF SUPPLIERS
2.1.5.
COMPETITIVE
RIVALRY
2.2.
LEGAL,
POLICY, & REGULATORY FRAMEWORK
2.3.
IMPACT
OF COVID-19 ON PHARMACEUTICAL FILTRATION MARKET
2.4.
MARKET
ATTRACTIVENESS INDEX
2.5.
VENDOR
SCORECARD
2.6.
KEY
INSIGHTS
2.7.
MARKET
DRIVERS
2.7.1.
SURGE
IN MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS
2.7.2.
INCREASING
HEALTHCARE EXPENDITURE
2.8.
MARKET
RESTRAINTS
2.8.1.
GROWING
EXPECTATIONS BY CUSTOMERS FOR HIGH-QUALITY DRUGS
2.8.2.
LACK
OF TRAINED PROFESSIONALS IN UNDERDEVELOPED COUNTRIES
2.9.
MARKET
OPPORTUNITIES
2.9.1.
RISING
ADVANCEMENTS IN BIOPHARMACEUTICAL INDUSTRY
2.9.2.
STRONGER
PRESENCE ESTABLISHMENT IN VARYING CONSUMER PREFERENCES
3.
ASIA-PACIFIC
PHARMACEUTICAL FILTRATION MARKET OUTLOOK - BY PRODUCT
3.1.
MEMBRANE
FILTERS
3.1.1.
MIXED
CELLULOSE ESTER (MCE) MEMBRANE FILTERS
3.1.2.
COATED
CELLULOSE ACETATE MEMBRANE FILTERS
3.1.3.
NYLON
MEMBRANE FILTERS
3.1.4.
PTFE
MEMBRANE FILTERS
3.1.5.
PVDF
MEMBRANE FILTERS
3.1.6.
OTHER
MEMBRANE FILTERS
3.2.
PREFILTER
& DEPTH FILTER MEDIA
3.3.
CARTRIDGE
& CAPSULES
3.4.
SINGLE-USE
SYSTEMS
3.5.
FILTER
HOLDERS
3.6.
FILTRATION
ACCESSORIES
3.7.
OTHER
PRODUCTS
4.
ASIA-PACIFIC
PHARMACEUTICAL FILTRATION MARKET OUTLOOK - BY TECHNIQUE TYPE
4.1.
MICROFILTRATION
4.2.
NANOFILTRATION
4.3.
ULTRAFILTRATION
4.4.
OTHER
TECHNIQUES
5.
ASIA-PACIFIC
PHARMACEUTICAL FILTRATION MARKET OUTLOOK - BY APPLICATION
5.1.
FINAL
PRODUCT PROCESSING
5.1.1.
STERILE
FILTRATION
5.1.2.
PROTEIN
PURIFICATION
5.1.3.
VACCINE
AND ANTIBODY PROCESSING
5.1.4.
ACTIVE
PHARMACEUTICAL INGREDIENT FILTRATION
5.1.5.
OTHER
FINAL PRODUCT PROCESSING
5.2.
RAW
MATERIAL FILTRATION
5.3.
CELL
SEPARATION
5.4.
WATER
PURIFICATION
5.5.
AIR
PURIFICATION
6.
GEOGRAPHICAL
ANALYSIS – ASIA-PACIFIC
6.1.
COUNTRY
ANALYSIS
6.1.1.
CHINA
6.1.2.
JAPAN
6.1.3.
INDIA
6.1.4.
AUSTRALIA
& NEW ZEALAND
6.1.5.
SOUTH
KOREA
6.1.6.
ASEAN
COUNTRIES
6.1.7.
REST
OF ASIA-PACIFIC
7.
COMPANY
PROFILES
7.1.
MICRODYN-NADIR
7.2.
SARTORIUS
STEDIM BIOTECH SA
7.3.
PALL
CORPORATION (DANAHER CORPORATION)
7.4.
GEA
GROUP AG
7.5.
GRAVER
TECHNOLOGIES LLC
7.6.
COORSTEK
INC
7.7.
GE
HEALTHCARE
7.8.
ASAHI
KASEI CORPORATION
7.9.
PARKER-HANNIFIN
CORPORATION
7.10. AMAZON
FILTERS LTD
7.11. DUPONT
7.12. CANTEL
MEDICAL CORPORATION
7.13. THERMO
FISHER SCIENTIFIC INC
7.14. SIEMENS
HEALTHINEERS
7.15. MERCK
& CO INC
7.16. 3M
COMPANY
8.
RESEARCH
METHODOLOGY & SCOPE
8.1.
RESEARCH
SCOPE & DELIVERABLES
8.1.1.
OBJECTIVES
OF STUDY
8.1.2.
SCOPE
OF STUDY
8.2.
SOURCES
OF DATA
8.2.1.
PRIMARY
DATA SOURCES
8.2.2.
SECONDARY
DATA SOURCES
8.3.
RESEARCH
METHODOLOGY
8.3.1.
EVALUATION
OF PROPOSED MARKET
8.3.2.
IDENTIFICATION
OF DATA SOURCES
8.3.3.
ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
TABLE
1 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE
2 VENDOR LANDSCAPE
TABLE
3 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE
4 ASIA-PACIFIC MEMBRANE FILTERS
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE
5 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY TECHNIQUE TYPE, 2021-2028 (IN $ MILLION)
TABLE
6 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE
7 ASIA-PACIFIC FINAL PRODUCT
PROCESSING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8 ASIA-PACIFIC
PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET 2021-2028 (IN $ MILLION)
FIGURE
2 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY MEMBRANE FILTERS, 2021-2028 (IN $ MILLION)
FIGURE
3 ASIA-PACIFIC MEMBRANE FILTERS
MARKET, BY MIXED CELLULOSE ESTER (MCE) MEMBRANE FILTERS, 2021-2028 (IN $
MILLION)
FIGURE
4 ASIA-PACIFIC MEMBRANE FILTERS
MARKET, BY COATED CELLULOSE ACETATE MEMBRANE FILTERS, 2021-2028 (IN $ MILLION)
FIGURE
5 ASIA-PACIFIC MEMBRANE FILTERS
MARKET, BY NYLON MEMBRANE FILTERS, 2021-2028 (IN $ MILLION)
FIGURE
6 ASIA-PACIFIC MEMBRANE FILTERS
MARKET, BY PTFE MEMBRANE FILTERS, 2021-2028 (IN $ MILLION)
FIGURE
7 ASIA-PACIFIC MEMBRANE FILTERS
MARKET, BY PVDF MEMBRANE FILTERS, 2021-2028 (IN $ MILLION)
FIGURE
8 ASIA-PACIFIC MEMBRANE FILTERS
MARKET, BY OTHER MEMBRANE FILTERS, 2021-2028 (IN $ MILLION)
FIGURE
9 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY PREFILTER & DEPTH FILTER MEDIA, 2021-2028 (IN $
MILLION)
FIGURE
10 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY CARTRIDGE & CAPSULES, 2021-2028 (IN $ MILLION)
FIGURE
11 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY SINGLE-USE SYSTEMS, 2021-2028 (IN $ MILLION)
FIGURE
12 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY FILTER HOLDERS, 2021-2028 (IN $ MILLION)
FIGURE
13 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY FILTRATION ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE
14 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE
15 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY MICROFILTRATION, 2021-2028 (IN $ MILLION)
FIGURE
16 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY NANOFILTRATION, 2021-2028 (IN $ MILLION)
FIGURE
17 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY ULTRAFILTRATION, 2021-2028 (IN $ MILLION)
FIGURE
18 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY OTHER TECHNIQUES, 2021-2028 (IN $ MILLION)
FIGURE
19 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY FINAL PRODUCT PROCESSING, 2021-2028 (IN $ MILLION)
FIGURE
20 ASIA-PACIFIC FINAL PRODUCT PROCESSING
MARKET, BY STERILE FILTRATION, 2021-2028 (IN $ MILLION)
FIGURE
21 ASIA-PACIFIC FINAL PRODUCT PROCESSING
MARKET, BY PROTEIN PURIFICATION, 2021-2028 (IN $ MILLION)
FIGURE
22 ASIA-PACIFIC FINAL PRODUCT PROCESSING
MARKET, BY VACCINE AND ANTIBODY PROCESSING, 2021-2028 (IN $ MILLION)
FIGURE
23 ASIA-PACIFIC FINAL PRODUCT PROCESSING
MARKET, BY ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION, 2021-2028 (IN $
MILLION)
FIGURE
24 ASIA-PACIFIC FINAL PRODUCT PROCESSING
MARKET, BY OTHER FINAL PRODUCT PROCESSING, 2021-2028 (IN $ MILLION)
FIGURE
25 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY RAW MATERIAL FILTRATION, 2021-2028 (IN $ MILLION)
FIGURE
26 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY CELL SEPARATION, 2021-2028 (IN $ MILLION)
FIGURE
27 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY WATER PURIFICATION, 2021-2028 (IN $ MILLION)
FIGURE
28 ASIA-PACIFIC PHARMACEUTICAL
FILTRATION MARKET, BY AIR PURIFICATION, 2021-2028 (IN $ MILLION)
FIGURE
29 CHINA PHARMACEUTICAL FILTRATION
MARKET 2021-2028 (IN $ MILLION)
FIGURE
30 JAPAN PHARMACEUTICAL FILTRATION
MARKET 2021-2028 (IN $ MILLION)
FIGURE
31 INDIA PHARMACEUTICAL FILTRATION
MARKET 2021-2028 (IN $ MILLION)
FIGURE
32 AUSTRALIA & NEW ZEALAND
PHARMACEUTICAL FILTRATION MARKET 2021-2028 (IN $ MILLION)
FIGURE
33 SOUTH KOREA PHARMACEUTICAL FILTRATION
MARKET 2021-2028 (IN $ MILLION)
FIGURE
34 ASEAN COUNTRIES PHARMACEUTICAL
FILTRATION MARKET 2021-2028 (IN $ MILLION)
FIGURE 35 REST
OF ASIA-PACIFIC PHARMACEUTICAL FILTRATION MARKET 2021-2028 (IN $ MILLION)